These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18821067)

  • 1. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
    Guney S; Guney N; Sonmez NC; Ergenekon E
    Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular cancer.
    Nichols CR
    Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
    Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
    Pont J; Albrecht W; Postner G; Sellner F; Angel K; Höltl W
    J Clin Oncol; 1996 Feb; 14(2):441-8. PubMed ID: 8636755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late relapse of germ cell tumors after cisplatin-based chemotherapy.
    Gerl A; Clemm C; Schmeller N; Hentrich M; Lamerz R; Wilmanns W
    Ann Oncol; 1997 Jan; 8(1):41-7. PubMed ID: 9093706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
    Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
    Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
    Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
    Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours.
    Maroto P; García del Muro X; Aparicio J; Paz-Ares L; Arranz JA; Guma J; Terrassa J; Barnadas J; Dorta J; Germà-Lluch JR
    Ann Oncol; 2005 Dec; 16(12):1915-20. PubMed ID: 16126737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.
    Behnia M; Foster R; Einhorn LH; Donohue J; Nichols CR
    Eur J Cancer; 2000 Mar; 36(4):472-5. PubMed ID: 10717522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
    Alexandre J; Fizazi K; Mahé C; Culine S; Droz JP; Théodore C; Terrier-Lacombe MJ
    Eur J Cancer; 2001 Mar; 37(5):576-82. PubMed ID: 11290432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.
    Oliver RT; Ong J; Shamash J; Ravi R; Nagund V; Harper P; Ostrowski MJ; Sizer B; Levay J; Robinson A; Neal DE; Williams M;
    Urology; 2004 Mar; 63(3):556-61. PubMed ID: 15028457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).
    Germà-Lluch JR; Garcia del Muro X; Maroto P; Paz-Ares L; Arranz JA; Gumà J; Alba E; Sastre J; Aparicio J; Fernández A; Barnadas A; Terrassa J; Sáenz A; Almenar D; López-Brea M; Climent MA; Sánchez MA; Lasso de la Vega R; Berenguer G; Pérez X;
    Eur Urol; 2002 Dec; 42(6):553-62; discussion 562-3. PubMed ID: 12477650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.